25 XP   0   0   10

Tonghua Dongbao Pharmaceutical Co Ltd
Buy, Hold or Sell?

Let's analyse Tonghua Dongbao Pharmaceutical Co Ltd together

PenkeI guess you are interested in Tonghua Dongbao Pharmaceutical Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Tonghua Dongbao Pharmaceutical Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Tonghua Dongbao Pharmaceutical Co Ltd

I send you an email if I find something interesting about Tonghua Dongbao Pharmaceutical Co Ltd.

Quick analysis of Tonghua Dongbao Pharmaceutical Co Ltd (30 sec.)










What can you expect buying and holding a share of Tonghua Dongbao Pharmaceutical Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.00
When do you have the money?
1 year
How often do you get paid?
90.0%

What is your share worth?

Current worth
¥3.62
Expected worth in 1 year
¥3.95
How sure are you?
90.0%

+ What do you gain per year?

Total Gains per Share
¥0.34
Return On Investment
3.4%

For what price can you sell your share?

Current Price per Share
¥10.03
Expected price per share
¥8.7507171806167 - ¥12.48
How sure are you?
50%

1. Valuation of Tonghua Dongbao Pharmaceutical Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥10.03

Intrinsic Value Per Share

¥3.79 - ¥5.72

Total Value Per Share

¥7.41 - ¥9.34

2. Growth of Tonghua Dongbao Pharmaceutical Co Ltd (5 min.)




Is Tonghua Dongbao Pharmaceutical Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$997.2m$920.5m$25.8m2.7%

How much money is Tonghua Dongbao Pharmaceutical Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$40.3m$54.6m-$14.3m-35.5%
Net Profit Margin37.6%55.3%--

How much money comes from the company's main activities?

3. Financial Health of Tonghua Dongbao Pharmaceutical Co Ltd (5 min.)




What can you expect buying and holding a share of Tonghua Dongbao Pharmaceutical Co Ltd? (5 min.)

Welcome investor! Tonghua Dongbao Pharmaceutical Co Ltd's management wants to use your money to grow the business. In return you get a share of Tonghua Dongbao Pharmaceutical Co Ltd.

What can you expect buying and holding a share of Tonghua Dongbao Pharmaceutical Co Ltd?

First you should know what it really means to hold a share of Tonghua Dongbao Pharmaceutical Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Tonghua Dongbao Pharmaceutical Co Ltd is ¥10.03. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Tonghua Dongbao Pharmaceutical Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Tonghua Dongbao Pharmaceutical Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥3.62. Based on the TTM, the Book Value Change Per Share is ¥0.08 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.06 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Tonghua Dongbao Pharmaceutical Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.030.3%0.020.2%0.030.3%0.020.2%0.020.2%
Usd Book Value Change Per Share0.030.3%0.010.1%0.010.1%0.010.1%0.010.1%
Usd Dividend Per Share0.000.0%0.000.0%0.030.3%0.010.1%0.010.1%
Usd Total Gains Per Share0.030.3%0.010.1%0.040.4%0.020.2%0.020.2%
Usd Price Per Share1.50-1.51-1.32-1.70-2.23-
Price to Earnings Ratio13.24-19.61-16.51-26.07-49.49-
Price-to-Total Gains Ratio55.95-35.68-3.55-71.15-108.35-
Price to Book Ratio2.99-3.19-2.88-4.41-8.74-
Price-to-Total Gains Ratio55.95-35.68-3.55-71.15-108.35-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.386146
Number of shares721
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.01
Usd Book Value Change Per Share0.010.01
Usd Total Gains Per Share0.010.02
Gains per Quarter (721 shares)8.3916.43
Gains per Year (721 shares)33.5465.73
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
103324372856
2067587557122
311009211285188
41133126149114254
51167160187142320
61200194224170386
71233228261199452
82267262299227518
92300296336256584
102333330373284650

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%79.00.08.090.8%
Book Value Change Per Share3.01.00.075.0%8.04.00.066.7%14.06.00.070.0%27.013.00.067.5%62.025.00.071.3%
Dividend per Share1.00.03.025.0%9.00.03.075.0%17.00.03.085.0%36.00.04.090.0%69.00.018.079.3%
Total Gains per Share3.01.00.075.0%10.02.00.083.3%18.02.00.090.0%36.04.00.090.0%76.011.00.087.4%

Fundamentals of Tonghua Dongbao Pharmaceutical Co Ltd

About Tonghua Dongbao Pharmaceutical Co Ltd

Tonghua Dongbao Pharmaceutical Co., Ltd. researches and develops, manufactures, and sells pharmaceutical for the treatment of diabetes, endocrine, and cardiovascular and cerebrovascular diseases products in China. The company operates through Pharmaceutical Industry; Building Materials Industry; and Real Estate Industry segments. It offers human insulin raw materials and injection, insulin glargine raw materials and injection, insulin aspart API and injection, Zhennaoning capsules, and diabetes-related medical devices. Further, it provides insulin pen and needle injection system, blood sugar monitoring system, and online and offline patient management system. It offers building materials.Tonghua Dongbao Pharmaceutical Co., Ltd. was founded in 1985 and is based in Tonghua, China.

Fundamental data was last updated by Penke on 2024-04-17 10:58:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is overpriced.

1.1. Profitability of Tonghua Dongbao Pharmaceutical Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Tonghua Dongbao Pharmaceutical Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Tonghua Dongbao Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 41.4% means that ¥0.41 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Tonghua Dongbao Pharmaceutical Co Ltd:

  • The MRQ is 41.4%. The company is making a huge profit. +2
  • The TTM is 37.6%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ41.4%TTM37.6%+3.8%
TTM37.6%YOY55.3%-17.7%
TTM37.6%5Y38.8%-1.2%
5Y38.8%10Y33.9%+4.9%
1.1.2. Return on Assets

Shows how efficient Tonghua Dongbao Pharmaceutical Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Tonghua Dongbao Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 5.2% Return on Assets means that Tonghua Dongbao Pharmaceutical Co Ltd generated ¥0.05 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Tonghua Dongbao Pharmaceutical Co Ltd:

  • The MRQ is 5.2%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 4.0%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ5.2%TTM4.0%+1.2%
TTM4.0%YOY5.6%-1.6%
TTM4.0%5Y4.5%-0.5%
5Y4.5%10Y4.1%+0.4%
1.1.3. Return on Equity

Shows how efficient Tonghua Dongbao Pharmaceutical Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Tonghua Dongbao Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 5.7% Return on Equity means Tonghua Dongbao Pharmaceutical Co Ltd generated ¥0.06 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Tonghua Dongbao Pharmaceutical Co Ltd:

  • The MRQ is 5.7%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 4.2%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ5.7%TTM4.2%+1.4%
TTM4.2%YOY5.8%-1.6%
TTM4.2%5Y4.8%-0.6%
5Y4.8%10Y4.7%+0.1%

1.2. Operating Efficiency of Tonghua Dongbao Pharmaceutical Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Tonghua Dongbao Pharmaceutical Co Ltd is operating .

  • Measures how much profit Tonghua Dongbao Pharmaceutical Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Tonghua Dongbao Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Tonghua Dongbao Pharmaceutical Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM10.1%-10.1%
TTM10.1%YOY28.5%-18.4%
TTM10.1%5Y29.9%-19.8%
5Y29.9%10Y17.4%+12.5%
1.2.2. Operating Ratio

Measures how efficient Tonghua Dongbao Pharmaceutical Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 0.69 means that the operating costs are ¥0.69 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Tonghua Dongbao Pharmaceutical Co Ltd:

  • The MRQ is 0.686. The company is efficient in keeping operating costs low. +1
  • The TTM is 0.785. The company is efficient in keeping operating costs low. +1
Trends
Current periodCompared to+/- 
MRQ0.686TTM0.785-0.100
TTM0.785YOY0.945-0.159
TTM0.7855Y0.849-0.064
5Y0.84910Y0.595+0.254

1.3. Liquidity of Tonghua Dongbao Pharmaceutical Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Tonghua Dongbao Pharmaceutical Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 5.41 means the company has ¥5.41 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Tonghua Dongbao Pharmaceutical Co Ltd:

  • The MRQ is 5.414. The company is very able to pay all its short-term debts. +2
  • The TTM is 8.342. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ5.414TTM8.342-2.927
TTM8.342YOY11.236-2.895
TTM8.3425Y7.886+0.455
5Y7.88610Y4.227+3.659
1.3.2. Quick Ratio

Measures if Tonghua Dongbao Pharmaceutical Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Tonghua Dongbao Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 1.63 means the company can pay off ¥1.63 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Tonghua Dongbao Pharmaceutical Co Ltd:

  • The MRQ is 1.631. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.517. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.631TTM2.517-0.886
TTM2.517YOY3.351-0.834
TTM2.5175Y2.698-0.181
5Y2.69810Y1.944+0.755

1.4. Solvency of Tonghua Dongbao Pharmaceutical Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Tonghua Dongbao Pharmaceutical Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Tonghua Dongbao Pharmaceutical Co Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.07 means that Tonghua Dongbao Pharmaceutical Co Ltd assets are financed with 7.1% credit (debt) and the remaining percentage (100% - 7.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Tonghua Dongbao Pharmaceutical Co Ltd:

  • The MRQ is 0.071. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.049. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.071TTM0.049+0.023
TTM0.049YOY0.043+0.005
TTM0.0495Y0.065-0.016
5Y0.06510Y0.136-0.071
1.4.2. Debt to Equity Ratio

Measures if Tonghua Dongbao Pharmaceutical Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Tonghua Dongbao Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 7.7% means that company has ¥0.08 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Tonghua Dongbao Pharmaceutical Co Ltd:

  • The MRQ is 0.077. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.052. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.077TTM0.052+0.025
TTM0.052YOY0.046+0.006
TTM0.0525Y0.071-0.019
5Y0.07110Y0.177-0.106

2. Market Valuation of Tonghua Dongbao Pharmaceutical Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Tonghua Dongbao Pharmaceutical Co Ltd generates.

  • Above 15 is considered overpriced but always compare Tonghua Dongbao Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 13.24 means the investor is paying ¥13.24 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Tonghua Dongbao Pharmaceutical Co Ltd:

  • The EOD is 12.262. Based on the earnings, the company is underpriced. +1
  • The MRQ is 13.240. Based on the earnings, the company is underpriced. +1
  • The TTM is 19.607. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD12.262MRQ13.240-0.978
MRQ13.240TTM19.607-6.367
TTM19.607YOY16.505+3.102
TTM19.6075Y26.071-6.464
5Y26.07110Y49.489-23.418
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Tonghua Dongbao Pharmaceutical Co Ltd:

  • The EOD is 15.662. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 16.911. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 72.170. Based on how much money comes from the company's main activities, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD15.662MRQ16.911-1.249
MRQ16.911TTM72.170-55.259
TTM72.170YOY10.852+61.318
TTM72.1705Y22.970+49.200
5Y22.97010Y65.352-42.382
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Tonghua Dongbao Pharmaceutical Co Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Tonghua Dongbao Pharmaceutical Co Ltd:

  • The EOD is 2.771. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.992. Based on the equity, the company is underpriced. +1
  • The TTM is 3.194. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD2.771MRQ2.992-0.221
MRQ2.992TTM3.194-0.202
TTM3.194YOY2.878+0.316
TTM3.1945Y4.414-1.220
5Y4.41410Y8.736-4.322
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Tonghua Dongbao Pharmaceutical Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.1910.084+129%0.057+237%0.071+169%0.065+194%
Book Value Per Share--3.6203.435+5%3.327+9%2.923+24%2.289+58%
Current Ratio--5.4148.342-35%11.236-52%7.886-31%4.227+28%
Debt To Asset Ratio--0.0710.049+46%0.043+65%0.065+10%0.136-47%
Debt To Equity Ratio--0.0770.052+49%0.046+68%0.071+8%0.177-56%
Dividend Per Share--0.0020.001+300%0.211-99%0.094-98%0.088-98%
Eps--0.2040.146+40%0.197+4%0.143+43%0.110+86%
Free Cash Flow Per Share--0.1600.064+149%0.046+246%0.071+125%0.070+130%
Free Cash Flow To Equity Per Share--0.1600.064+149%-0.114+171%-0.007+104%0.038+318%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--5.723--------
Intrinsic Value_10Y_min--3.790--------
Intrinsic Value_1Y_max--0.322--------
Intrinsic Value_1Y_min--0.261--------
Intrinsic Value_3Y_max--1.158--------
Intrinsic Value_3Y_min--0.892--------
Intrinsic Value_5Y_max--2.227--------
Intrinsic Value_5Y_min--1.636--------
Market Cap19996008279.040-8%21590904253.44021850401724.730-1%19190524693.140+13%25172901023.608-14%32618445690.367-34%
Net Profit Margin--0.4140.376+10%0.553-25%0.388+7%0.339+22%
Operating Margin---0.101-100%0.285-100%0.299-100%0.174-100%
Operating Ratio--0.6860.785-13%0.945-27%0.849-19%0.595+15%
Pb Ratio2.771-8%2.9923.194-6%2.878+4%4.414-32%8.736-66%
Pe Ratio12.262-8%13.24019.607-32%16.505-20%26.071-49%49.489-73%
Price Per Share10.030-8%10.83010.960-1%9.585+13%12.298-12%16.123-33%
Price To Free Cash Flow Ratio15.662-8%16.91172.170-77%10.852+56%22.970-26%65.352-74%
Price To Total Gains Ratio51.818-8%55.95135.684+57%3.547+1478%71.149-21%108.350-48%
Quick Ratio--1.6312.517-35%3.351-51%2.698-40%1.944-16%
Return On Assets--0.0520.040+31%0.056-6%0.045+16%0.041+29%
Return On Equity--0.0570.042+33%0.058-3%0.048+17%0.047+19%
Total Gains Per Share--0.1940.084+130%0.268-28%0.165+17%0.153+27%
Usd Book Value--997290520.542946347400.419+5%920544350.159+8%820741193.044+22%641141901.906+56%
Usd Book Value Change Per Share--0.0260.012+129%0.008+237%0.010+169%0.009+194%
Usd Book Value Per Share--0.5000.475+5%0.460+9%0.404+24%0.316+58%
Usd Dividend Per Share--0.0000.000+300%0.029-99%0.013-98%0.012-98%
Usd Eps--0.0280.020+40%0.027+4%0.020+43%0.015+86%
Usd Free Cash Flow--44111946.35817737821.355+149%12834152.777+244%20169286.638+119%19476217.889+126%
Usd Free Cash Flow Per Share--0.0220.009+149%0.006+246%0.010+125%0.010+130%
Usd Free Cash Flow To Equity Per Share--0.0220.009+149%-0.016+171%-0.001+104%0.005+318%
Usd Market Cap2763448344.163-8%2983862967.8253019725518.358-1%2652130512.592+13%3478894921.463-14%4507869194.409-34%
Usd Price Per Share1.386-8%1.4971.515-1%1.325+13%1.700-12%2.228-33%
Usd Profit--56341454.30740348710.230+40%54654359.497+3%40071804.910+41%30707784.237+83%
Usd Revenue--135977913.454106255623.809+28%95995553.195+42%102206395.082+33%87033514.303+56%
Usd Total Gains Per Share--0.0270.012+130%0.037-28%0.023+17%0.021+27%
 EOD+4 -4MRQTTM+27 -8YOY+20 -155Y+24 -1110Y+26 -9

3.2. Fundamental Score

Let's check the fundamental score of Tonghua Dongbao Pharmaceutical Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1512.262
Price to Book Ratio (EOD)Between0-12.771
Net Profit Margin (MRQ)Greater than00.414
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.631
Current Ratio (MRQ)Greater than15.414
Debt to Asset Ratio (MRQ)Less than10.071
Debt to Equity Ratio (MRQ)Less than10.077
Return on Equity (MRQ)Greater than0.150.057
Return on Assets (MRQ)Greater than0.050.052
Total7/10 (70.0%)

3.3. Technical Score

Let's check the technical score of Tonghua Dongbao Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5046.217
Ma 20Greater thanMa 5010.186
Ma 50Greater thanMa 10010.120
Ma 100Greater thanMa 20010.477
OpenGreater thanClose10.100
Total3/5 (60.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Net Interest Income  4,018-7583,259513,310-1,9001,410-3,813-2,403



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets7,771,367
Total Liabilities555,082
Total Stockholder Equity7,211,199
 As reported
Total Liabilities 555,082
Total Stockholder Equity+ 7,211,199
Total Assets = 7,771,367

Assets

Total Assets7,771,367
Total Current Assets2,816,355
Long-term Assets4,955,012
Total Current Assets
Cash And Cash Equivalents 1,104,204
Short-term Investments 55,516
Net Receivables 793,065
Inventory 705,346
Other Current Assets 38,304
Total Current Assets  (as reported)2,816,355
Total Current Assets  (calculated)2,696,436
+/- 119,919
Long-term Assets
Property Plant Equipment 2,670,682
Intangible Assets 1,338,255
Long-term Assets Other 355,476
Long-term Assets  (as reported)4,955,012
Long-term Assets  (calculated)4,364,413
+/- 590,599

Liabilities & Shareholders' Equity

Total Current Liabilities520,161
Long-term Liabilities34,921
Total Stockholder Equity7,211,199
Total Current Liabilities
Short Long Term Debt 150,000
Accounts payable 115,903
Other Current Liabilities 1,663
Total Current Liabilities  (as reported)520,161
Total Current Liabilities  (calculated)267,566
+/- 252,595
Long-term Liabilities
Long-term Liabilities  (as reported)34,921
Long-term Liabilities  (calculated)0
+/- 34,921
Total Stockholder Equity
Retained Earnings 3,697,417
Total Stockholder Equity (as reported)7,211,199
Total Stockholder Equity (calculated)3,697,417
+/- 3,513,782
Other
Capital Stock1,993,617
Common Stock Shares Outstanding 1,993,617
Net Invested Capital 7,361,199
Net Working Capital 2,296,194
Property Plant and Equipment Gross 2,670,682



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-06-302000-12-312000-06-30
> Total Assets 
1,516,386
1,469,113
1,426,645
1,456,506
1,456,058
1,479,995
1,542,449
1,568,533
1,629,691
1,646,059
1,654,302
1,795,126
1,862,952
1,871,525
1,875,500
1,806,248
1,801,361
1,856,996
1,908,489
1,884,953
1,959,853
1,992,571
1,963,546
1,967,111
2,051,692
2,094,575
2,121,175
2,268,966
2,293,420
2,319,495
2,208,468
2,171,286
2,242,539
2,281,295
2,286,326
2,251,440
2,238,073
2,207,827
2,214,845
2,186,335
2,225,359
2,342,888
2,588,738
2,377,343
2,441,166
2,304,469
2,381,726
2,380,120
2,522,942
2,466,793
2,629,658
2,694,453
2,661,844
2,775,232
2,939,375
2,956,219
3,064,632
3,120,887
3,410,006
3,788,130
3,942,583
3,948,867
4,623,836
4,675,009
4,759,154
4,758,978
4,851,941
4,752,716
5,039,564
5,465,220
5,486,790
5,463,327
6,006,385
5,646,672
5,340,280
5,349,910
5,836,597
5,675,913
5,497,560
5,803,260
6,131,589
6,020,304
6,307,935
6,520,102
7,303,545
6,912,465
6,885,010
6,750,314
6,998,080
6,842,129
7,203,787
7,771,367
7,771,3677,203,7876,842,1296,998,0806,750,3146,885,0106,912,4657,303,5456,520,1026,307,9356,020,3046,131,5895,803,2605,497,5605,675,9135,836,5975,349,9105,340,2805,646,6726,006,3855,463,3275,486,7905,465,2205,039,5644,752,7164,851,9414,758,9784,759,1544,675,0094,623,8363,948,8673,942,5833,788,1303,410,0063,120,8873,064,6322,956,2192,939,3752,775,2322,661,8442,694,4532,629,6582,466,7932,522,9422,380,1202,381,7262,304,4692,441,1662,377,3432,588,7382,342,8882,225,3592,186,3352,214,8452,207,8272,238,0732,251,4402,286,3262,281,2952,242,5392,171,2862,208,4682,319,4952,293,4202,268,9662,121,1752,094,5752,051,6921,967,1111,963,5461,992,5711,959,8531,884,9531,908,4891,856,9961,801,3611,806,2481,875,5001,871,5251,862,9521,795,1261,654,3021,646,0591,629,6911,568,5331,542,4491,479,9951,456,0581,456,5061,426,6451,469,1131,516,386
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,657,695
2,400,552
2,273,232
2,628,291
2,321,636
1,983,706
1,926,634
2,276,239
1,994,830
1,760,732
1,922,421
2,203,154
2,049,391
2,125,374
2,162,461
2,905,860
2,454,520
2,326,861
2,056,413
2,228,094
2,006,592
2,280,667
2,816,355
2,816,3552,280,6672,006,5922,228,0942,056,4132,326,8612,454,5202,905,8602,162,4612,125,3742,049,3912,203,1541,922,4211,760,7321,994,8302,276,2391,926,6341,983,7062,321,6362,628,2912,273,2322,400,5522,657,695000000000000000000000000000000000000000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
510,124
399,000
355,983
767,860
442,596
336,320
368,013
708,309
464,137
267,328
593,375
596,222
414,824
510,793
865,040
1,039,713
1,078,768
1,210,506
788,063
858,224
518,168
662,332
1,104,204
1,104,204662,332518,168858,224788,0631,210,5061,078,7681,039,713865,040510,793414,824596,222593,375267,328464,137708,309368,013336,320442,596767,860355,983399,000510,124000000000000000000000000000000000000000000000000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
318,900
0
323,000
0
324,100
0
0
0
0
0
150,369
413,236
374,000
337,398
37,000
589,000
300,000
42,000
58,462
36,000
51,000
54,500
55,516
55,51654,50051,00036,00058,46242,000300,000589,00037,000337,398374,000413,236150,36900000324,1000323,0000318,900000000000000000000000000000000000000000000000000000000000000000000000
       Net Receivables 
661,387
642,283
605,363
519,740
0
538,118
588,040
612,948
683,503
652,433
637,616
629,422
675,445
700,981
696,208
568,693
581,120
522,620
549,816
523,025
531,599
506,469
466,278
410,786
419,233
438,882
435,214
402,435
431,960
454,346
463,237
460,782
477,081
482,669
491,132
441,828
453,780
443,431
446,764
412,375
428,868
471,121
515,208
479,794
505,082
484,411
555,026
387,847
433,155
442,286
469,611
396,221
408,083
424,848
562,579
430,520
447,154
428,091
461,989
415,751
432,744
410,636
442,635
476,658
486,720
532,871
612,297
558,075
711,407
790,500
663,588
650,120
569,590
615,937
556,358
697,086
686,347
687,459
674,176
589,323
586,558
668,056
703,997
658,572
645,088
388,714
365,116
476,545
542,478
649,465
706,136
793,065
793,065706,136649,465542,478476,545365,116388,714645,088658,572703,997668,056586,558589,323674,176687,459686,347697,086556,358615,937569,590650,120663,588790,500711,407558,075612,297532,871486,720476,658442,635410,636432,744415,751461,989428,091447,154430,520562,579424,848408,083396,221469,611442,286433,155387,847555,026484,411505,082479,794515,208471,121428,868412,375446,764443,431453,780441,828491,132482,669477,081460,782463,237454,346431,960402,435435,214438,882419,233410,786466,278506,469531,599523,025549,816522,620581,120568,693696,208700,981675,445629,422637,616652,433683,503612,948588,040538,1180519,740605,363642,283661,387
       Inventory 
71,284
72,962
92,565
98,459
0
105,755
94,783
95,869
110,760
128,256
147,425
126,556
139,288
145,886
166,678
140,598
144,820
150,360
163,068
139,779
141,093
143,817
149,101
140,090
147,621
159,259
162,787
145,472
138,723
148,768
161,815
145,619
153,061
170,965
178,395
170,111
161,798
180,377
190,243
187,411
189,201
214,756
233,857
197,780
199,905
214,358
214,066
232,994
206,207
228,730
226,386
343,779
310,743
328,703
382,412
629,583
592,887
705,858
738,849
954,772
942,022
959,755
899,802
1,047,949
954,192
999,463
983,537
973,916
894,266
900,665
856,888
901,024
825,310
721,206
671,895
628,759
576,793
538,215
514,574
537,578
497,369
495,497
508,901
537,918
521,040
576,125
616,999
653,895
699,897
710,383
712,452
705,346
705,346712,452710,383699,897653,895616,999576,125521,040537,918508,901495,497497,369537,578514,574538,215576,793628,759671,895721,206825,310901,024856,888900,665894,266973,916983,537999,463954,1921,047,949899,802959,755942,022954,772738,849705,858592,887629,583382,412328,703310,743343,779226,386228,730206,207232,994214,066214,358199,905197,780233,857214,756189,201187,411190,243180,377161,798170,111178,395170,965153,061145,619161,815148,768138,723145,472162,787159,259147,621140,090149,101143,817141,093139,779163,068150,360144,820140,598166,678145,886139,288126,556147,425128,256110,76095,86994,783105,755098,45992,56572,96271,284
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,378,094
3,325,036
3,356,574
3,423,276
3,560,358
3,681,082
3,736,828
3,880,839
3,928,435
3,970,913
4,182,561
4,357,641
4,397,685
4,457,945
4,558,149
4,693,901
4,769,986
4,835,537
4,923,119
4,955,012
4,955,0124,923,1194,835,5374,769,9864,693,9014,558,1494,457,9454,397,6854,357,6414,182,5613,970,9133,928,4353,880,8393,736,8283,681,0823,560,3583,423,2763,356,5743,325,0363,378,094000000000000000000000000000000000000000000000000000000000000000000000000
       Property Plant Equipment 
486,004
515,231
496,768
622,271
0
610,910
607,531
673,092
651,545
661,469
659,297
732,064
730,739
725,689
722,100
807,700
801,650
841,326
845,342
886,600
907,122
909,629
895,840
1,107,663
1,135,633
1,181,091
1,210,340
1,241,372
1,218,992
1,248,835
1,222,777
1,253,427
1,221,500
1,194,963
1,187,969
1,204,651
1,181,931
1,167,894
1,134,210
1,171,641
1,133,293
1,142,375
1,126,467
1,110,113
1,071,196
1,134,082
1,107,765
1,263,085
1,239,409
1,284,275
1,256,086
1,288,368
1,254,653
1,241,665
1,224,434
1,279,865
1,252,668
1,277,909
1,378,853
1,586,928
1,697,841
1,734,823
1,880,161
1,851,379
1,842,271
1,841,644
1,869,632
1,873,414
1,862,224
1,859,717
2,017,762
1,959,727
1,991,227
2,081,328
2,086,237
2,111,006
2,104,658
2,175,720
2,243,503
2,287,572
2,301,892
2,289,729
2,333,422
2,392,106
2,397,683
2,461,948
2,566,523
2,678,424
2,689,596
2,675,237
2,684,122
2,670,682
2,670,6822,684,1222,675,2372,689,5962,678,4242,566,5232,461,9482,397,6832,392,1062,333,4222,289,7292,301,8922,287,5722,243,5032,175,7202,104,6582,111,0062,086,2372,081,3281,991,2271,959,7272,017,7621,859,7171,862,2241,873,4141,869,6321,841,6441,842,2711,851,3791,880,1611,734,8231,697,8411,586,9281,378,8531,277,9091,252,6681,279,8651,224,4341,241,6651,254,6531,288,3681,256,0861,284,2751,239,4091,263,0851,107,7651,134,0821,071,1961,110,1131,126,4671,142,3751,133,2931,171,6411,134,2101,167,8941,181,9311,204,6511,187,9691,194,9631,221,5001,253,4271,222,7771,248,8351,218,9921,241,3721,210,3401,181,0911,135,6331,107,663895,840909,629907,122886,600845,342841,326801,650807,700722,100725,689730,739732,064659,297661,469651,545673,092607,531610,9100622,271496,768515,231486,004
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
335,918
328,067
326,245
330,725
335,376
339,762
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000339,762335,376330,725326,245328,067335,918000000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
76,576
32,971
32,134
34,741
0
33,594
36,531
30,579
31,472
35,628
36,469
31,239
30,574
29,539
31,271
31,973
27,038
21,281
25,128
15,060
23,458
91,826
97,878
86,106
94,341
80,898
95,454
87,174
106,418
70,384
101,139
65,123
97,410
76,713
91,513
55,593
82,799
71,213
79,540
54,010
75,665
49,772
60,465
46,477
74,310
42,163
70,666
39,229
67,090
36,063
63,452
36,066
62,384
60,571
58,411
56,292
54,209
53,567
51,851
49,609
47,429
45,159
42,888
124,882
117,120
109,907
105,055
97,438
89,725
82,140
193,427
239,325
406,084
237,236
439,888
472,570
483,186
553,777
574,876
608,757
625,145
675,315
734,560
796,649
836,037
941,496
994,213
1,069,084
1,123,976
1,223,310
1,271,024
1,338,255
1,338,2551,271,0241,223,3101,123,9761,069,084994,213941,496836,037796,649734,560675,315625,145608,757574,876553,777483,186472,570439,888237,236406,084239,325193,42782,14089,72597,438105,055109,907117,120124,88242,88845,15947,42949,60951,85153,56754,20956,29258,41160,57162,38436,06663,45236,06367,09039,22970,66642,16374,31046,47760,46549,77275,66554,01079,54071,21382,79955,59391,51376,71397,41065,123101,13970,384106,41887,17495,45480,89894,34186,10697,87891,82623,45815,06025,12821,28127,03831,97331,27129,53930,57431,23936,46935,62831,47230,57936,53133,594034,74132,13432,97176,576
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
556,399
389,847
397,585
373,124
500,043
477,878
2,681,783
418,573
424,695
442,580
560,860
569,582
626,591
563,518
504,307
425,419
417,251
400,174
402,958
355,476
355,476402,958400,174417,251425,419504,307563,518626,591569,582560,860442,580424,695418,5732,681,783477,878500,043373,124397,585389,847556,399000000000000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
87,695
44,104
52,276
77,960
0
54,241
104,897
205,519
258,448
258,993
256,749
393,949
450,499
451,617
454,214
480,119
468,185
511,817
560,600
544,229
611,294
618,681
648,254
691,132
729,797
738,779
758,528
734,971
742,676
750,053
750,865
737,661
737,916
746,161
697,565
624,745
601,549
545,763
508,072
453,749
455,570
555,371
457,838
299,374
317,138
295,099
318,814
388,923
458,270
517,991
609,016
678,228
566,533
798,110
843,507
795,715
778,207
923,798
1,058,863
1,309,110
1,302,696
1,402,725
873,826
729,763
611,202
687,873
496,036
215,295
228,528
734,540
605,492
729,058
998,727
788,545
326,701
341,099
617,743
597,193
206,129
243,801
343,950
308,236
323,140
299,874
301,998
176,201
528,563
200,740
200,012
300,445
369,162
555,082
555,082369,162300,445200,012200,740528,563176,201301,998299,874323,140308,236343,950243,801206,129597,193617,743341,099326,701788,545998,727729,058605,492734,540228,528215,295496,036687,873611,202729,763873,8261,402,7251,302,6961,309,1101,058,863923,798778,207795,715843,507798,110566,533678,228609,016517,991458,270388,923318,814295,099317,138299,374457,838555,371455,570453,749508,072545,763601,549624,745697,565746,161737,916737,661750,865750,053742,676734,971758,528738,779729,797691,132648,254618,681611,294544,229560,600511,817468,185480,119454,214451,617450,499393,949256,749258,993258,448205,519104,89754,241077,96052,27644,10487,695
   > Total Current Liabilities 
87,631
44,062
52,276
76,296
71,650
52,277
53,797
153,565
206,697
205,839
200,791
343,052
399,373
400,571
403,718
379,789
367,856
411,388
431,271
450,204
430,973
368,451
372,506
375,522
412,442
421,417
441,170
421,573
428,478
436,655
437,466
424,762
424,817
432,113
383,517
321,229
301,424
248,991
239,702
169,194
170,524
273,919
185,867
163,370
180,532
161,319
155,326
136,028
184,303
229,634
310,412
375,037
263,437
449,409
493,479
460,653
441,374
597,252
742,625
1,026,729
1,020,674
1,138,564
727,526
639,033
520,807
597,814
454,083
174,987
188,555
694,902
566,190
691,402
961,406
751,559
290,050
304,847
581,820
558,077
128,965
208,183
308,666
273,288
288,528
268,552
271,011
145,550
498,248
162,053
164,335
265,104
334,185
520,161
520,161334,185265,104164,335162,053498,248145,550271,011268,552288,528273,288308,666208,183128,965558,077581,820304,847290,050751,559961,406691,402566,190694,902188,555174,987454,083597,814520,807639,033727,5261,138,5641,020,6741,026,729742,625597,252441,374460,653493,479449,409263,437375,037310,412229,634184,303136,028155,326161,319180,532163,370185,867273,919170,524169,194239,702248,991301,424321,229383,517432,113424,817424,762437,466436,655428,478421,573441,170421,417412,442375,522372,506368,451430,973450,204431,271411,388367,856379,789403,718400,571399,373343,052200,791205,839206,697153,56553,79752,27771,65076,29652,27644,06287,631
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
700,000
550,000
120,000
125,000
400,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000400,000125,000120,000550,000700,000000000000000000000000000000000000000000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
700,000
550,000
120,000
125,000
400,000
400,000
0
0
0
0
0
0
0
0
0
0
0
70,000
150,000
150,000
150,000150,00070,00000000000000400,000400,000125,000120,000550,000700,000000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
9,864
28,738
26,168
29,276
0
15,263
18,430
39,670
30,700
32,591
28,665
40,700
35,184
36,398
36,648
45,211
39,120
35,023
49,481
44,415
34,930
28,138
32,663
43,138
35,609
42,587
47,394
40,843
49,096
36,654
45,834
49,537
45,634
48,375
51,932
40,695
45,324
49,808
48,608
46,654
47,469
48,812
52,949
37,765
38,152
28,107
36,468
30,775
25,177
42,239
49,676
38,878
42,768
50,876
47,869
51,988
33,907
35,214
49,776
53,195
36,265
41,056
28,786
90,501
62,321
98,819
108,650
61,287
64,603
59,676
60,861
131,962
148,957
87,207
67,671
69,152
60,485
46,791
48,221
68,174
66,990
49,681
55,371
74,999
49,745
51,931
68,153
80,858
82,235
91,697
88,699
115,903
115,90388,69991,69782,23580,85868,15351,93149,74574,99955,37149,68166,99068,17448,22146,79160,48569,15267,67187,207148,957131,96260,86159,67664,60361,287108,65098,81962,32190,50128,78641,05636,26553,19549,77635,21433,90751,98847,86950,87642,76838,87849,67642,23925,17730,77536,46828,10738,15237,76552,94948,81247,46946,65448,60849,80845,32440,69551,93248,37545,63449,53745,83436,65449,09640,84347,39442,58735,60943,13832,66328,13834,93044,41549,48135,02339,12045,21136,64836,39835,18440,70028,66532,59130,70039,67018,43015,263029,27626,16828,7389,864
       Other Current Liabilities 
34,367
11,924
21,778
43,820
71,650
33,814
19,217
110,695
97,797
91,798
35,176
53,152
43,689
43,673
45,570
63,078
58,136
56,065
63,490
67,939
77,243
110,513
104,043
80,684
91,133
113,080
94,126
56,680
55,932
76,051
69,282
53,525
57,483
63,038
57,185
57,534
73,100
65,183
77,094
58,540
59,055
170,107
131,918
32,605
49,380
54,212
39,858
26,253
50,126
44,395
57,736
53,159
47,669
60,533
65,611
98,666
97,467
82,038
112,850
100,740
110,952
124,004
141,740
118,532
69,485
130,995
117,433
113,700
123,952
116,842
100,711
86,616
111,312
98,294
99,673
91,485
117,949
94,958
77,249
124,021
237,921
208,896
230,146
161,809
218,246
80,214
429,390
70,166
81,143
86,078
142
1,663
1,66314286,07881,14370,166429,39080,214218,246161,809230,146208,896237,921124,02177,24994,958117,94991,48599,67398,294111,31286,616100,711116,842123,952113,700117,433130,99569,485118,532141,740124,004110,952100,740112,85082,03897,46798,66665,61160,53347,66953,15957,73644,39550,12626,25339,85854,21249,38032,605131,918170,10759,05558,54077,09465,18373,10057,53457,18563,03857,48353,52569,28276,05155,93256,68094,126113,08091,13380,684104,043110,51377,24367,93963,49056,06558,13663,07845,57043,67343,68953,15235,17691,79897,797110,69519,21733,81471,65043,82021,77811,92434,367
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
37,321
36,986
36,651
36,252
35,923
39,116
77,164
35,619
35,283
34,948
34,613
31,322
30,986
30,651
30,315
38,687
35,677
35,340
34,976
34,921
34,92134,97635,34035,67738,68730,31530,65130,98631,32234,61334,94835,28335,61977,16439,11635,92336,25236,65136,98637,321000000000000000000000000000000000000000000000000000000000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,650
0
2,650
0
2,650
0
2,650
0
0
0
0
0
0
0
00000002,65002,65002,65002,650000000000000000000000000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
430,417
440,891
149,319
172,066
207,748
219,881
216,426
235,336
282,828
297,699
357,832
377,318
450,993
483,108
447,288
450,601
565,192
591,175
607,248
668,914
778,747
0
0
00778,747668,914607,248591,175565,192450,601447,288483,108450,993377,318357,832297,699282,828235,336216,426219,881207,748172,066149,319440,891430,417000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
1,395,370
1,417,941
1,366,788
1,372,059
0
1,386,149
1,398,022
1,322,034
1,330,632
1,344,903
1,353,666
1,358,169
1,366,899
1,373,637
1,374,769
1,279,920
1,285,056
1,296,004
1,298,238
1,296,115
1,302,434
1,326,365
1,267,581
1,233,059
1,279,618
1,313,218
1,322,326
1,491,991
1,509,205
1,527,994
1,416,183
1,393,784
1,464,994
1,497,402
1,552,365
1,592,887
1,604,018
1,630,096
1,675,574
1,699,645
1,737,330
1,755,280
2,099,622
2,046,027
2,092,847
1,978,248
2,031,350
1,961,704
2,036,552
1,921,117
1,993,570
1,991,181
2,070,987
1,953,216
2,072,201
2,137,748
2,264,413
2,175,386
2,329,998
2,459,317
2,620,880
2,539,283
3,742,598
3,939,220
4,142,236
4,065,224
4,349,871
4,527,850
4,801,652
4,722,296
4,873,199
4,724,292
4,997,920
4,849,638
5,005,619
5,000,395
5,210,826
5,071,138
5,285,470
5,553,989
5,782,143
5,706,643
5,979,221
6,214,879
6,996,227
6,730,955
6,351,209
6,544,263
6,792,833
6,536,398
6,829,350
7,211,199
7,211,1996,829,3506,536,3986,792,8336,544,2636,351,2096,730,9556,996,2276,214,8795,979,2215,706,6435,782,1435,553,9895,285,4705,071,1385,210,8265,000,3955,005,6194,849,6384,997,9204,724,2924,873,1994,722,2964,801,6524,527,8504,349,8714,065,2244,142,2363,939,2203,742,5982,539,2832,620,8802,459,3172,329,9982,175,3862,264,4132,137,7482,072,2011,953,2162,070,9871,991,1811,993,5701,921,1172,036,5521,961,7042,031,3501,978,2482,092,8472,046,0272,099,6221,755,2801,737,3301,699,6451,675,5741,630,0961,604,0181,592,8871,552,3651,497,4021,464,9941,393,7841,416,1831,527,9941,509,2051,491,9911,322,3261,313,2181,279,6181,233,0591,267,5811,326,3651,302,4341,296,1151,298,2381,296,0041,285,0561,279,9201,374,7691,373,6371,366,8991,358,1691,353,6661,344,9031,330,6321,322,0341,398,0221,386,14901,372,0591,366,7881,417,9411,395,370
   Common Stock
324,493
324,493
324,493
324,493
0
324,493
324,493
324,493
324,493
324,493
324,493
324,493
324,493
324,493
324,493
324,493
324,493
324,493
324,493
324,493
324,493
387,572
368,572
368,572
368,572
368,572
368,572
368,572
368,572
368,572
368,572
368,572
368,572
479,144
479,144
479,144
479,144
574,972
574,972
574,972
574,972
776,213
776,213
776,213
776,213
776,213
776,213
776,213
776,213
931,455
931,455
931,455
931,455
1,024,601
1,030,101
1,030,101
1,030,101
1,133,111
1,135,831
1,135,831
1,135,831
1,362,997
1,418,724
1,421,934
1,421,934
1,706,320
1,711,297
1,711,297
1,711,297
2,053,556
2,053,556
2,033,989
2,033,989
2,033,989
2,033,989
2,033,989
2,033,989
2,033,989
2,033,989
2,033,989
2,033,989
2,033,989
2,033,989
2,033,989
2,009,589
2,009,589
1,993,679
1,993,679
1,993,679
0
0
0
0001,993,6791,993,6791,993,6792,009,5892,009,5892,033,9892,033,9892,033,9892,033,9892,033,9892,033,9892,033,9892,033,9892,033,9892,033,9892,033,9892,033,9892,033,9892,053,5562,053,5561,711,2971,711,2971,711,2971,706,3201,421,9341,421,9341,418,7241,362,9971,135,8311,135,8311,135,8311,133,1111,030,1011,030,1011,030,1011,024,601931,455931,455931,455931,455776,213776,213776,213776,213776,213776,213776,213776,213574,972574,972574,972574,972479,144479,144479,144479,144368,572368,572368,572368,572368,572368,572368,572368,572368,572368,572368,572387,572324,493324,493324,493324,493324,493324,493324,493324,493324,493324,493324,493324,493324,493324,493324,493324,4930324,493324,493324,493324,493
   Retained Earnings 
220,533
234,459
188,350
189,999
0
208,055
219,929
138,489
147,088
161,359
170,121
167,778
176,508
183,247
184,379
87,625
92,761
103,709
105,943
100,260
106,579
130,510
146,966
110,509
157,068
187,527
196,635
212,221
229,434
248,224
267,877
252,792
278,437
281,817
327,216
320,112
358,052
403,131
445,221
482,730
517,393
538,709
891,547
808,825
852,228
730,974
785,733
708,331
774,841
670,345
741,396
716,493
1,040,202
829,540
899,753
960,205
1,082,178
913,678
1,040,264
1,144,134
1,305,697
1,004,975
1,190,271
1,330,725
1,533,742
1,172,342
1,410,540
1,598,505
1,872,307
1,450,692
1,601,594
1,752,592
1,481,994
1,333,712
1,489,692
2,157,000
2,434,469
2,294,782
2,509,114
2,679,235
3,015,893
2,928,044
3,321,805
3,566,555
4,397,762
4,149,244
3,873,535
4,052,665
4,303,101
3,014,382
3,289,737
3,697,417
3,697,4173,289,7373,014,3824,303,1014,052,6653,873,5354,149,2444,397,7623,566,5553,321,8052,928,0443,015,8932,679,2352,509,1142,294,7822,434,4692,157,0001,489,6921,333,7121,481,9941,752,5921,601,5941,450,6921,872,3071,598,5051,410,5401,172,3421,533,7421,330,7251,190,2711,004,9751,305,6971,144,1341,040,264913,6781,082,178960,205899,753829,5401,040,202716,493741,396670,345774,841708,331785,733730,974852,228808,825891,547538,709517,393482,730445,221403,131358,052320,112327,216281,817278,437252,792267,877248,224229,434212,221196,635187,527157,068110,509146,966130,510106,579100,260105,943103,70992,76187,625184,379183,247176,508167,778170,121161,359147,088138,489219,929208,0550189,999188,350234,459220,533
   Capital Surplus 00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000000000-16,500-16,500-16,500-28,875-28,875-28,875-28,875-28,875-28,875-28,875-28,8750000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,272
3,272
4,825
4,825
4,825
4,825
8,251
8,251
8,251
8,251
7,483
7,483
7,483
7,483
6,939
6,939
6,939
6,939
6,386
6,386
0
0
0
0006,3866,3866,9396,9396,9396,9397,4837,4837,4837,4838,2518,2518,2518,2514,8254,8254,8254,8253,2723,272000000000000000000000000000000000000000000000000000000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue3,075,416
Cost of Revenue-612,771
Gross Profit2,462,6452,462,645
 
Operating Income (+$)
Gross Profit2,462,645
Operating Expense-1,772,833
Operating Income1,302,584689,813
 
Operating Expense (+$)
Research Development104,959
Selling General Administrative956,525
Selling And Marketing Expenses0
Operating Expense1,772,8331,061,484
 
Net Interest Income (+$)
Interest Income-11,678
Interest Expense-4,535
Other Finance Cost-21,789
Net Interest Income5,576
 
Pretax Income (+$)
Operating Income1,302,584
Net Interest Income5,576
Other Non-Operating Income Expenses0
Income Before Tax (EBT)1,365,8971,302,584
EBIT - interestExpense = -4,535
1,167,835
1,172,370
Interest Expense4,535
Earnings Before Interest and Taxes (EBIT)01,370,432
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax1,365,897
Tax Provision-197,974
Net Income From Continuing Ops1,167,9221,167,922
Net Income1,167,835
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-5,576
 

Technical Analysis of Tonghua Dongbao Pharmaceutical Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Tonghua Dongbao Pharmaceutical Co Ltd. The general trend of Tonghua Dongbao Pharmaceutical Co Ltd is BEARISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Tonghua Dongbao Pharmaceutical Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-57.1%) Bearish trend (57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Tonghua Dongbao Pharmaceutical Co Ltd.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 11.02 < 11.09 < 12.48.

The bearish price targets are: 9.88 > 9.82 > 8.7507171806167.

Tweet this
Tonghua Dongbao Pharmaceutical Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Tonghua Dongbao Pharmaceutical Co Ltd. The current mas is .

The long score for the Moving Averages is 3/14.
The longshort score for the Moving Averages is -8/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Tonghua Dongbao Pharmaceutical Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Tonghua Dongbao Pharmaceutical Co Ltd. The current macd is -0.03188473.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Tonghua Dongbao Pharmaceutical Co Ltd price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Tonghua Dongbao Pharmaceutical Co Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Tonghua Dongbao Pharmaceutical Co Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Tonghua Dongbao Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartTonghua Dongbao Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Tonghua Dongbao Pharmaceutical Co Ltd. The current adx is 10.62.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Tonghua Dongbao Pharmaceutical Co Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Tonghua Dongbao Pharmaceutical Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Tonghua Dongbao Pharmaceutical Co Ltd. The current sar is 10.89.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Tonghua Dongbao Pharmaceutical Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Tonghua Dongbao Pharmaceutical Co Ltd. The current rsi is 46.22. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Tonghua Dongbao Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) ChartTonghua Dongbao Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Tonghua Dongbao Pharmaceutical Co Ltd. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Tonghua Dongbao Pharmaceutical Co Ltd price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Tonghua Dongbao Pharmaceutical Co Ltd Daily Stochastic Oscillator ChartTonghua Dongbao Pharmaceutical Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Tonghua Dongbao Pharmaceutical Co Ltd. The current cci is -62.72339444.

Tonghua Dongbao Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) ChartTonghua Dongbao Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Tonghua Dongbao Pharmaceutical Co Ltd. The current cmo is -11.84520118.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Tonghua Dongbao Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) ChartTonghua Dongbao Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Tonghua Dongbao Pharmaceutical Co Ltd. The current willr is -89.07563025.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Tonghua Dongbao Pharmaceutical Co Ltd Daily Williams %R ChartTonghua Dongbao Pharmaceutical Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Tonghua Dongbao Pharmaceutical Co Ltd.

Tonghua Dongbao Pharmaceutical Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Tonghua Dongbao Pharmaceutical Co Ltd. The current atr is 0.28671249.

Tonghua Dongbao Pharmaceutical Co Ltd Daily Average True Range (ATR) ChartTonghua Dongbao Pharmaceutical Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Tonghua Dongbao Pharmaceutical Co Ltd. The current obv is 392,683,043.

Tonghua Dongbao Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) ChartTonghua Dongbao Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Tonghua Dongbao Pharmaceutical Co Ltd. The current mfi is 47.23.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Tonghua Dongbao Pharmaceutical Co Ltd Daily Money Flow Index (MFI) ChartTonghua Dongbao Pharmaceutical Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Tonghua Dongbao Pharmaceutical Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-30CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-01CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-04CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-29STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-11RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-18RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-29WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-30RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-19CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-04-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside

6.3. Candlestick Patterns

Tonghua Dongbao Pharmaceutical Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Tonghua Dongbao Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5046.217
Ma 20Greater thanMa 5010.186
Ma 50Greater thanMa 10010.120
Ma 100Greater thanMa 20010.477
OpenGreater thanClose10.100
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Tonghua Dongbao Pharmaceutical Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Tonghua Dongbao Pharmaceutical Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Tonghua Dongbao Pharmaceutical Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Tonghua Dongbao Pharmaceutical Co Ltd

I send you an email if I find something interesting about Tonghua Dongbao Pharmaceutical Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Tonghua Dongbao Pharmaceutical Co Ltd.

Receive notifications about Tonghua Dongbao Pharmaceutical Co Ltd in your mailbox!